Daily FNArena News

New research highlights the recent performance by Light & Wonder in Australia and the potential for replication in the US

Positive nuclear industry dynamics and a recent pullback in prices for ASX-listed uranium shares prompts a review of brokers’ favoured exposures

Brokers highlight deregulation and scale benefits from the potential merger of Integral Diagnostics and Capitol Health

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea is Seek

IG’s Tony Sycamore offers his technical views on the Nasdaq, the ASX200 and WTI sweet crude

Deterra Royalties is looking to diversify away from iron ore royalties and provide for growth, in lithium in particular. The trade-off is a much-reduced dividend yield

Price action suggests shares in James Hardie have seen the low and are now poised for upside, reports Michael Gable of Fairmont Equities

Codan has surprised with the performance of its metal detection business, but it is the company’s communications business that has brokers excited

The next twelve months could be exciting for Dengue fever solutions seeker Island Therapeutics, the New Criterion’s Tim Boreham reports

Alternative asset manager Regal Partners has enjoyed impressive organic and inorganic funds under management growth in recent years and brokers see more ahead